CAS 1346607-05-3

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

CAS: 1346607-05-3

Formula: C₂₆H₂₀ClN₃O₅

Purity: %

Color and Shape: Solid

Molecular weight: 489.9071

Ref: IN-DA01ENTP

Gsk621

CAS: 1346607-05-3

Gsk621

Formula: C₂₆H₂₀ClN₃O₅

Purity: 98+%

Molecular weight: 489.91

Ref: 54-OR1024378

GSK621

CAS: 1346607-05-3

GSK621

Formula: C₂₆H₂₀ClN₃O₅

Purity: ≥95%

Molecular weight: 489.91

Ref: 54-BUP03201

GSK621

CAS: 1346607-05-3

GSK621 is a specific and potent AMPK activator.

Formula: C₂₆H₂₀ClN₃O₅

Purity: 97.02% - 97.05%

Color and Shape: Solid

Molecular weight: 489.91

Ref: TM-T6854

GSK621

CAS: 1346607-05-3

6-Chloro-5-(2'-hydroxy-3'-methoxy-[1,1'-biphenyl]-4-yl)-3-(3-methoxyphenyl)-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione

Formula: C₂₆H₂₀ClN₃O₅

Purity: 98+%

Molecular weight: 489.91

Ref: IN-DG764852

GSK621

CAS: 1346607-05-3

GSK621 is a selective inhibitor, which is synthesized for research purposes in the modulation of enzymatic activity. This compound is sourced through synthetic chemical processes and designed to selectively target the phosphoinositide 3-kinase (PI3K) pathway. GSK621's mode of action involves the inhibition of the PI3K pathway, a critical signaling pathway involved in cellular functions such as growth, proliferation, and survival. By inhibiting this pathway, GSK621 can modulate aberrant signaling commonly observed in various cancers.

Formula: C₂₆H₂₀ClN₃O₅

Purity: Min. 95%

Molecular weight: 489.91 g/mol

Ref: 3D-WDC60705